Skip to main content
HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.59
+0.14 (1.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed

HUTCHMED (China) Revenue

In the year 2025, HUTCHMED (China) had annual revenue of $548.51M, down -12.96%. HUTCHMED (China) had revenue of $270.84M in the half year ending December 31, 2025, a decrease of -11.24%.

Revenue (ttm)
$548.51M
Revenue Growth
-12.96%
P/S Ratio
4.28
Revenue / Employee
$305,408
Employees
1,796
Market Cap
2.35B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025548.51M-81.69M-12.96%
Dec 31, 2024630.20M-207.80M-24.80%
Dec 31, 2023838.00M411.59M96.52%
Dec 31, 2022426.41M70.28M19.73%
Dec 31, 2021356.13M128.15M56.21%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Perrigo Company 4.25B
Phibro Animal Health 1.46B
Prestige Consumer Healthcare 1.10B
ANI Pharmaceuticals 883.37M
BioCryst Pharmaceuticals 874.84M
Supernus Pharmaceuticals 718.95M
Kiniksa Pharmaceuticals International, 677.56M
Revenue Rankings

HCM News

More News